Hybridmøtet 26. oktober om guidelines og type 1 diabetes
Kasuistikkene forslag til løsning fra Dr. Peter Adolfsson
Kasuistikk fra Stavanger Universitetssykehus
Kasuistikk fra Vestre Viken,Kongsberg Sykehus
Kasuistikk fra Aker Sykehus
Kasuistikk fra Ahus
Last ned karbohydrat-tabell
Reduced mortality rate
Moving from sedentary to physical activity thrice a week seems to reduce the mortality risk more than what happens with reducing HbA1c1
Competitive athlete
Being a competitive athlete with T1D can be challenging, but several strategies can be implemented to help glycaemic management
(Fig 2)7
Personalised diabetes management
Each type of exercise has different outcome on glucose trend and requires personalized diabetes management2,3
Exercise management
Variability is observed in blood glucose responses to different forms of exercise in people with T1D (Fig 1)4
ISPAD exercise guidelines
- The guidelines cover many broad aspects of exercise and diabetes for children and adolescents with T1D and T2D3
- Describes insulin pump/MDI insulin adjustments and nutrition recommendations for before, immediately after and overnight for aerobic, mixed and anaerobic activity
- Guidance on AID systems and exercise
Preventing hypos
- CGM devices can provide intermittently scanned or real-time glucose data before, during and after exercise5
- Sensor glucose value should be interpreted together with the corresponding trend arrow
Evidence-based recommendations
According to 37 evidence-based clinical practice recommendations in AACE guideline6:
- CGM is recommended to everyone on insulin
- Lifestyle and other factors should be considered
- Real-time CGM is easier for anyone doing exercise
Tools & apps
Direct integration of CGM with smartwatch instead of transferring via smartphone
Dexcom offers direct integration with Apple Watch on the G7
In AppEx, a sensor sends respective values to the app and an alarm is triggered in critical situations signalling the amount of carbs or insulin needed
Dette kan også være av interesse
Autoimmune Type 1 Diabetes
The Type 1 Diabetes (T1D) field is evolving.
Recognition of the presymptomatic stages in T1D is growing.1-4
The clinical benefits of early detection of T1D are being highlighted.3-4 Programmes focusing on early detection through testing and screening for presymptomatic autoimmune T1D are increasingly offered to risk populations and the general population.1,2
A Paradigm Shift in Early Detection of Autoimmune Type 1 Diabetes
Autoimmune Type 1 diabetes (T1D) is undergoing a fundamental transformation in how the medical community approaches diagnosis and care.
